Darcy Ellen Hamill, DO

Hematology/Oncology

Primary Office

Nemours Children's Hospital, Delaware Nemours Children's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803 Appointment: (800) 416-4441

Get to Know Me

I am a pediatric hematologist/oncologist at Nemours and a clinical assistant professor at Sidney Kimmel Medical College. When I’m not at work, I am most likely spending time with my husband and our two daughters. 

Why I Treat Children

Children have a particular innocence and resilience that motivates me in the work I do. I love that in pediatrics there is a constant team effort to foster positivity and joy. I am in awe of the incredible strength of my amazing patients.

What I'm Passionate About

I am passionate about providing exceptional care to my patients and bringing novel, effective therapies to the bedside. I specialize in taking care of children with leukemia as well as children who need a stem cell transplant or cellular therapy.

How I Try to Make A Difference

I understand that I am meeting my patients and families on what seems like the worst day of their lives. I honor the difficult journey that they are about to undertake and the role I have in leading them on that journey. I make every effort to spend time with patients and families, making sure they have all the information they need regarding a diagnosis and treatment plan and that they know there is no question they can’t ask me. I also involve myself with research at Nemours in an effort to make sure that we are providing novel therapies to our current patients, as well as advancing the field for future patients. 

Education & Training

Fellowship

  • Pediatric Hematology/Oncology - Nemours/Alfred I. duPont Hospital for Children, 2020

Internship Residency

  • Pediatrics - New York Medical College / Westchester Medical Ctr, 2017

Medical/Dental School

  • Osteopathic Physician - New York College of Osteopathic Medicine, 2014

Board Certifications

  • American Board of Pediatrics/Pediatric Hematology-Oncology
  • American Board of Pediatrics/General Pediatrics

Insurance Accepted

  • Aetna Better Health PA Kids HMO
  • Aetna HMO
  • Aetna PPO/EPO/POS
  • Aetna PPO/POS/EPO
  • Amerihealth Caritas DE - PENNSYLVANIA SPECIALISTS ONLY
  • Amerihealth Caritas Delaware
  • Amerihealth Caritas Delaware NJ
  • Carefirst MD Community Health Plan Mcaid
  • Cigna & Great West HMO/POS/EPO
  • Cigna & Great West PPO
  • Cigna Lifesource Transplant
  • Cigna/Great West HMO EPO POS
  • Cigna/Great West PPO
  • Delaware First Health
  • Delaware Medicaid/Diamond State
  • Delaware Medicare
  • Devon Health Services
  • Fidelis Care NJ Medicaid HMO
  • First Health PPO
  • First Health/Affordable PPO
  • Geisinger Health Plan Commercial
  • Global Medical Managment DE/PA
  • Global Medical Mangment NJ
  • Health Partners Medicaid/Kidz Partner HMO
  • Highmark Blue Cross Blue Shield of Delaware
  • Highmark Blue Cross Blue Shield of Pennsylvania
  • Highmark Medicaid Health Options
  • Horizon Blue Cross Blue Shield of New Jersey
  • Independance Blue Cross/Amerihealth/Keystone Health Plan
  • Insurance Administrators of America
  • INTEGRA Administrative Group (ClaimsBridge)
  • Keystone First Medicaid HMO
  • Lifetrac Transplant
  • Maryland Medicaid
  • Multiplan PPO
  • New Jersey Medicaid
  • Olympus Managed Healthcare PPO DE/PA
  • Pennsylvania Medicaid
  • Plan Vista/NPPN PPO
  • Preferred Healthcare PPO
  • Private Health Care Systems (PHCS)
  • Private Healthcare Systems (PHCS)
  • Qualcare HMO/POS/PPO
  • Star Healthcare Network
  • Three Rivers Provider Network
  • Tricare/Humana Military Health Services
  • United Healthcare of the Mid-Atlantic
  • UPMC MCAID/CHIP PA DE
  • UPMC Medicaid
  • US Family Health Plan
  • Wellpoint Maryland Medcaid

  • Blood and Bone Marrow Transplantation
  • Cancer Care
  • Leukemia
  • Lymphoma
  • Neuroblastoma
  • Neutropenia

  • Gopalakrishnapillai, A., Correnti, C. E., Pilat, K., Lin, I., Chan, M. K., Bandaranayake, A. D., & Barwe, S. P. (2021). Immunotherapeutic targeting of mesothelin positive pediatric aml using bispecific t cell engaging antibodies. Cancers, 13(23). doi:10.3390/cancers13235964

  • Kinnaman, Hamill, D., Yabe, M., Powell, J., Benhamida, J., Hasselblatt, M., & Shukla, N. (2020). Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1. JCO Precision Oncology, 4, 1280-1284. doi:10.1200/PO.20.00215

  • English